DexCom, Inc. (DXCM) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-12

How it makes money

Patients and their insurers pay for glucose monitoring systems.

Most customers rely on third-party payors, such as government programs or private health insurance, to cover the cost of the devices.

Because these payors control the money, their reimbursement rates and coverage decisions drive the company's revenue.

What protects it: the moat

Dexcom relies on high accuracy and integration with other health devices.

The company claims its G7 15 Day is the most accurate CGM cleared by the FDA.

It also designs its systems to work within a large ecosystem of insulin pumps and smartwatches.

What growth costs

The company invests in new technology and new patient groups.

Dexcom must reinvest in developing future generations of its technology.

It also seeks to expand its offerings to new markets, such as people with prediabetes or obesity.

What could damage it

New government bidding processes could force lower reimbursement rates.

The Centers for Medicare & Medicaid Services is moving to a competitive bidding process.

This change is expected to result in reduced Medicare payment for CGM systems starting in 2028.

About DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

More on DXCM

Other companies in Medical Devices